Abbott expects to reopen, produce formula in 2 weeks

GRAND RAPIDS, Michigan (WOOD) — Abbott Laboratories speaks out against the White House over the nationwide infant formula shortage and the Sturgis plant shutdown.

on a friday White House press conference, spokesperson Jennifer Psaki noted how the formula shortage has been partly caused by the closure of the Sturgis plant. “But we think the best steps we can take is to work with Abbott, and Abbott here also has a responsibility to work closely with the FDA and take the steps needed to get back online and operational.” to become.”

The Food and Drug Administration (FDA) closed the Sturgis facility in February after a cluster of infant hospitalizations, including two infant deaths, from a rare bacterial infection.

Abbott released a series of 11 tweetsthe first to say: “During the White House press conference today, the press secretary falsely said that our formulas were contaminated and killed two babies. The death of these children is a tragedy.”

Abbott’s tweets argued that FDA and CDC investigations found no evidence that the formulas caused the teething problems.

Abbott also tweeted that “genetic sequencing on the two available samples from sick babies did not match strains of Cronobacter in our plant. Samples from sick babies did not match, meaning there was no association between the two cases.” And, “In all four cases, the state, FDA and/or CDC tested samples of the Abbott formula used by the child. In all four cases, all unopened containers tested negative.”

A statement on Abbott’s website notes that the Sturgis plant could soon be back up and running: “…we have been working to address the FDA’s 483 observations so we can resume operations at the Sturgis, Michigan facility. We immediately began implementing corrective actions and subject to FDA approval, we were able to restart our site in Sturgis, Michigan within two weeks.”

Abbott has increased infant formula production at its FDA-registered plants in Ireland and Columbus, Ohio.

Leave a Comment

Your email address will not be published.